FGD1
Basic information
Region (hg38): X:54445454-54496234
Previous symbols: [ "FGDY" ]
Links
Phenotypes
GenCC
Source:
- Aarskog-Scott syndrome, X-linked (Supportive), mode of inheritance: AD
- Aarskog-Scott syndrome, X-linked (Strong), mode of inheritance: XL
- Aarskog-Scott syndrome, X-linked (Definitive), mode of inheritance: XL
- Aarskog-Scott syndrome, X-linked (Definitive), mode of inheritance: XL
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Aarskog-Scott syndrome | XL | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Genitourinary; Musculoskeletal; Neurologic | 5504078; 5173168; 7954831; 10930571; 11093277; 15809997; 17152066; 17847065; 19110080; 20082460; 21654724; 21739585; 22876573 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (338 variants)
- Inborn_genetic_diseases (103 variants)
- Aarskog_syndrome (80 variants)
- FGD1-related_disorder (33 variants)
- not_specified (19 variants)
- Intellectual_disability (12 variants)
- Syndromic_X-linked_intellectual_disability_Claes-Jensen_type (2 variants)
- History_of_neurodevelopmental_disorder (2 variants)
- TSR2-related_disorder (2 variants)
- Russell-Silver_syndrome (1 variants)
- Polyhydramnios (1 variants)
- Neurodevelopmental_delay (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FGD1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000004463.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 75 | 12 | 95 | |||
missense | 11 | 174 | 40 | 234 | ||
nonsense | 10 | 20 | ||||
start loss | 0 | |||||
frameshift | 24 | 11 | 39 | |||
splice donor/acceptor (+/-2bp) | 13 | |||||
Total | 45 | 37 | 188 | 115 | 16 |
Highest pathogenic variant AF is 0.00249395
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FGD1 | protein_coding | protein_coding | ENST00000375135 | 18 | 50713 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000301 | 125679 | 2 | 3 | 125684 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.52 | 215 | 417 | 0.515 | 0.0000357 | 6169 |
Missense in Polyphen | 40 | 129.7 | 0.30839 | 1847 | ||
Synonymous | 0.353 | 164 | 170 | 0.966 | 0.0000143 | 2000 |
Loss of Function | 4.92 | 2 | 32.0 | 0.0624 | 0.00000245 | 505 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000115 | 0.0000981 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000640 | 0.0000462 |
European (Non-Finnish) | 0.0000122 | 0.00000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.000226 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Activates CDC42, a member of the Ras-like family of Rho- and Rac proteins, by exchanging bound GDP for free GTP. Plays a role in regulating the actin cytoskeleton and cell shape. {ECO:0000269|PubMed:8969170}.;
- Disease
- DISEASE: Aarskog-Scott syndrome (AAS) [MIM:305400]: An X-linked recessive, rare multisystemic disorder characterized by disproportionately short stature, and by facial, skeletal and urogenital anomalies. Some patients manifest mental retardation, attention deficit disorder and hyperactivity. {ECO:0000269|PubMed:10930571, ECO:0000269|PubMed:11093277, ECO:0000269|PubMed:14560308}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in FGD1 are found in a patient with non- syndromal X-linked mental retardation. {ECO:0000269|PubMed:11940089}.;
- Pathway
- Regulation of actin cytoskeleton - Homo sapiens (human);Regulation of Actin Cytoskeleton;Signaling by GPCR;Signal Transduction;Rho GTPase cycle;Signaling by Rho GTPases;NRAGE signals death through JNK;Death Receptor Signalling;p75 NTR receptor-mediated signalling;G alpha (12/13) signalling events;GPCR downstream signalling;Regulation of CDC42 activity;Cell death signalling via NRAGE, NRIF and NADE
(Consensus)
Recessive Scores
- pRec
- 0.287
Intolerance Scores
- loftool
- 0.132
- rvis_EVS
- -0.51
- rvis_percentile_EVS
- 21.56
Haploinsufficiency Scores
- pHI
- 0.323
- hipred
- Y
- hipred_score
- 0.809
- ghis
- 0.552
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.506
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fgd1
- Phenotype
Gene ontology
- Biological process
- cytoskeleton organization;signal transduction;G protein-coupled receptor signaling pathway;multicellular organism development;regulation of cell shape;animal organ morphogenesis;actin cytoskeleton organization;regulation of Rho protein signal transduction;positive regulation of apoptotic process;regulation of GTPase activity;filopodium assembly;regulation of small GTPase mediated signal transduction
- Cellular component
- ruffle;cytoplasm;Golgi apparatus;cytosol;cytoskeleton;lamellipodium
- Molecular function
- guanyl-nucleotide exchange factor activity;Rho guanyl-nucleotide exchange factor activity;small GTPase binding;metal ion binding